Hancokinol is primarily studied for its anti-inflammatory and immunomodulatory properties. It has shown potential in reducing inflammatory markers in preclinical models, making it a candidate for research in autoimmune and chronic inflammatory diseases. The compound also exhibits antimicrobial activity, particularly against certain Gram-positive bacteria, suggesting possible use in developing new antimicrobial agents. Additionally, hancokinol has been investigated for its neuroprotective effects, with studies indicating it may help protect neuronal cells from oxidative stress and apoptosis, which could be relevant in neurodegenerative conditions. Its natural origin and biological activity profile support ongoing exploration in pharmaceutical and therapeutic applications.